Clonal Heterogeneity Influences Drug Responsiveness in Renal Cancer Assessed by Ex Vivo Drug Testing of Multiple Patient-Derived Cancer Cells

International Journal of Cancer - United States
doi 10.1002/ijc.31815
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Identification of Synergistic Drug Combinations Using Breast Cancer Patient-Derived Xenografts

Scientific Reports
Multidisciplinary
2020English

In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome

Cancers
Cancer ResearchOncology
2019English

Drug Induced Steatohepatitis in Patient With Breast Cancer

Thai Journal of Hepatology
2018English

Ex Vivo Tumor Culture Systems for Functional Drug Testing and Therapy Response Prediction

Future Science OA
MedicineBiotechnology
2017English

From Competency to Dormancy: A 3D Model to Study Cancer Cells and Drug Responsiveness

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Biomarkers and Multiple Drug Resistance in Breast Cancer

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2006English

Killing Cancer Cells by Targeted Drug-Carrying Phage Nanomedicines

BMC Biotechnology
Biotechnology
2008English

Killing Cancer Cells by Poly-Drug Elevation of Ceramide Levels

European Journal of Biochemistry
2001English

Discovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling

PLoS Computational Biology
Molecular NeuroscienceEvolutionEcologyGeneticsBehaviorMolecular BiologySystematicsSimulationCellularComputational TheoryMathematicsModeling
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy